Targeting XBP1-mediated β-catenin expression associated with bladder cancer with newly synthetic Oridonin analogues

Conventional chemotherapy is commonly used for advanced stages of transitional cell carcinoma (TCC) with modest success and high morbidity; however, TCC eventually develops resistance. Muscle invasive bladder cancer (MIBC) is recognized as a lethal disease due to its poor response to traditional che...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Wei, Zhou, Jiancheng, Wu, Kaijie, Huang, Jun, Ding, Ye, Yun, Eun-Jin, Wang, Bin, Ding, Chunyong, Hernandez, Elizabeth, Santoyo, John, Chen, Haiying, Lin, Ho, Sagalowsky, Arthur, He, Dalin, Zhou, Jia, Hsieh, Jer-Tsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302956/
https://www.ncbi.nlm.nih.gov/pubmed/27472396
http://dx.doi.org/10.18632/oncotarget.10863

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5302956/
https://www.ncbi.nlm.nih.gov/pubmed/27472396
http://dx.doi.org/10.18632/oncotarget.10863

Ejemplares similares